SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CF3DBBDB6C9C9FD5574D472D67AF9A6084C84C0A9D0CFB36A34AFE68F02CE425B0E24FCC4061D70AEB1C46EEC624D5A3>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CF3DBBDB6C9C9FD5574D472D67AF9A6084C84C0A9D0CFB36A34AFE68F02CE425B0E24FCC4061D70AEB1C46EEC624D5A3
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CF3DBBDB6C9C9FD5574D472D67AF9A6084C84C0A9D0CFB36A34AFE68F02CE425B0E24FCC4061D70AEB1C46EEC624D5A3
http://www.w3.org/2000/01/rdf-schema#comment
"Targeting TRAF2 may be useful as a therapeutic approach for immunosuppression-free islet allograft survival that avoids the thromboembolic complications associated with the use of anti-CD40L antibodies."
xsd:string
http://purl.uniprot.org/uniprot/#_C4AC588A0C75C96464CD6E92CDE41FEE85D8F56F77E86B753CFD597D8A3E1C2FA77D87D695E984C7F7732B1E407D509B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CF3DBBDB6C9C9FD5574D472D67AF9A6084C84C0A9D0CFB36A34AFE68F02CE425B0E24FCC4061D70AEB1C46EEC624D5A3
http://purl.uniprot.org/uniprot/Q8CAQ7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CF3DBBDB6C9C9FD5574D472D67AF9A6084C84C0A9D0CFB36A34AFE68F02CE425B0E24FCC4061D70AEB1C46EEC624D5A3
http://purl.uniprot.org/uniprot/#_Q8CAQ7-mappedCitation-28062921
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CF3DBBDB6C9C9FD5574D472D67AF9A6084C84C0A9D0CFB36A34AFE68F02CE425B0E24FCC4061D70AEB1C46EEC624D5A3